ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MXCT Maxcyte Inc

305.00
0.00 (0.00%)
Last Updated: 07:30:48
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Maxcyte Inc LSE:MXCT London Ordinary Share COM STK USD0.01 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 305.00 300.00 310.00 305.00 305.00 305.00 2,485 07:30:48
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 41.29M -37.92M -0.3664 -10.21 387.11M

MaxCyte, Inc. Block Admission Six Monthly Return/TVR (8340H)

20/11/2018 7:01am

UK Regulatory


Maxcyte (LSE:MXCT)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Maxcyte Charts.

TIDMMXCT TIDMMXCR

RNS Number : 8340H

MaxCyte, Inc.

20 November 2018

SCHEDULE 6

AIM BLOCK ADMISSION SIX MONTHLY RETURN / TOTAL VOTING RIGHTS

Please ensure the entries on this return are typed

a. Name of company

MaxCyte, Inc.

b. Name of scheme(s)

MaxCyte Long Term Incentive Plan

c. Period of return:

   From  15 January 2018                               To   16 November 2018 

d. Number and class of securities not issued under scheme

799,771 ordinary shares of common stock of $0.01 each

e. Number of shares issued under scheme during period

384,012 ordinary shares of common stock of $0.01 each

f. Balance under the scheme not yet issued at the end of the period.

415,759 ordinary shares of common stock of $0.01 each

g. Number and class of share(s) (amount of stock / debt securities) originally listed and the date of admission; If additional blocklisting application have been made, under this scheme, since the original listing application please also state the number of shares and the date(s) of admission.

1,000,000 ordinary shares of common stock of $0.01 each on 5 May 2017

Please confirm your total issued share capital as at the end of this period.

(If you hold any shares in Treasury state the figure separately);

51,298,681 (35,758,573 MXCT.L and 15,513,108 MXCR.L)

Treasury shares (if applicable) .........Nil.............

h. Contact name and telephone number for queries;

Doug Doerfler, Chief Executive Officer

Ron Holtz, Chief Financial Officer

+1 301 944 1660

Date

.

19 November 2018

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCUKOURWAAAAUA

(END) Dow Jones Newswires

November 20, 2018 02:01 ET (07:01 GMT)

1 Year Maxcyte Chart

1 Year Maxcyte Chart

1 Month Maxcyte Chart

1 Month Maxcyte Chart

Your Recent History

Delayed Upgrade Clock